Forgot your password?
New user?
Nanoparticle fear over anti-odour socks
Fragment-based Lead Discovery Conference 2008
test conference
Document Actions
CHI’S CANCER DIAGNOSTICS: NEXT GENERATION MOLECULAR TECHNOLOGIES
| Type | Conference |
|---|---|
| Date |
August 21, 2008
to August 22, 2008 |
| Venue |
The Ritz-Carlton Washington , DC US |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
CHI Representative Cambridge Healthtech Institute 250 First Ave Needham, MA 02494 US 781 972 5400 781 972 5425 chI@healthtech.com |
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
Advances in molecular diagnostics has enabled the detection of early stage tumors that will lead to greater success rates with intervention and treatment. Tests are being commercialized that employ a variety of approaches utilizing gene expression, serum biomarkers, and circulating tumors cells to capture information early for non-invasive screening of selected populations. Technologies to resolve and isolate the earliest stages of disease can be used in some cases in combination with imaging techniques to differentiate between benign vs. malignant tumors. The potential for these assays to greatly improve patient survival and care is historic and opportune and will further allow the tracking of disease progression. www.healthtech.com